[Genetics of type II diabetes]

Area of Science:

• Endocrinology and Genetics
• Molecular Biology

Background:

• Type 2 diabetes is a complex disease with diverse etiologies, ranging from environmental influences to strong genetic predispositions.
• Monogenic forms, like Maturity-Onset Diabetes of the Young (MODY), have been linked to specific gene mutations, including glucokinase and four transcription factors crucial for pancreatic development and glucose metabolism.
• The genetic architecture of more common, polygenic forms of type 2 diabetes remains less understood.

Purpose of the Study:

• To review the current understanding of genetic factors contributing to type 2 diabetes.
• To highlight the progress in identifying genes responsible for monogenic diabetes subtypes.
• To discuss the implications of discovering diabetes susceptibility genes for therapeutic development.

Main Methods:

• Review of genetic studies on type 2 diabetes, including gene identification for MODY subtypes.
• Analysis of genome scans in families with diabetes to identify susceptibility loci.
• Discussion of the role of identified genes and loci in disease pathogenesis.

Main Results:

• Five genes (glucokinase and four transcription factors) are identified as causative for autosomal dominant MODY.
• Several susceptibility loci for type 2 diabetes have been mapped to chromosomes 1q, 2p, 2q (including calpain 10), 3q, 12q, and 20.
• Minor genetic contributors like insulin and sulfamide receptor are also implicated.

Conclusions:

• Understanding the genetic basis of type 2 diabetes, from monogenic to polygenic forms, is crucial for unraveling disease mechanisms.
• The identification of specific genes and susceptibility loci provides a foundation for developing targeted therapies.
• Further research into genetic factors will advance the development of novel anti-diabetic drugs.